Outcome Evaluation

• To determine the efficacy of nonpharmacologic and pharmacotherapy for both STE and NSTE ACS, monitor patients for: (a) relief of ischemic discomfort; (b) return of ECG changes to baseline; and (c) absence or resolution of heart failure signs.

• Monitoring parameters for recognition and prevention of adverse effects from ACS pharmacotherapy are described in Table 8-4. In general, the most common adverse reactions from ACS therapies are hypotension and bleeding. To treat for bleeding and hypotension, discontinue the offending agent(s) until symptoms resolve. Severe bleeding resulting in hypotension secondary to hypovolemia may require blood transfusion.

The Prevention and Treatment of Headaches

The Prevention and Treatment of Headaches

Are Constant Headaches Making Your Life Stressful? Discover Proven Methods For Eliminating Even The Most Powerful Of Headaches, It’s Easier Than You Think… Stop Chronic Migraine Pain and Tension Headaches From Destroying Your Life… Proven steps anyone can take to overcome even the worst chronic head pain…

Get My Free Audio Book

Post a comment